|
The company made the announcement after market hours yesterday, 10 December 2015.
Meanwhile, the S&P BSE Sensex was down 19.76 points, or 0.08%, to 25,232.56
On BSE, so far 2,361 shares were traded in the counter as against average daily volume of 9,045 shares in the past one quarter.
The stock hit a high of Rs 390.25 and a low of Rs 385 so far during the day. The stock hit a record high of Rs 668.25 on 16 April 2015. The stock hit a 52-week low of Rs 370.20 on 18 November 2015.
The small-cap company has equity capital of Rs 10.32 crore. Face value per share is Rs 2.
Vinati Organics said that due to the long term tripartite agreement, the company's turnover is expected to increase by Rs 45 crore for the year ending 31 March 2017 (FY 2017).
Vinati Organics' net profit rose 9.3% to Rs 31.07 crore on 25.3% fall in net sales to Rs 143.91 crore in Q2 September 2015 over Q2 September 2014.
Vinati Organics manufactures isobutyl benzene, the prime raw material for the manufacture of ibuprofen, a vital bulk drug.
|